Literature DB >> 2058727

Longitudinal effect of captopril on aortic and arteriolar development in normotensive rats.

D H Wang1, R L Prewitt.   

Abstract

Normotensive rats were chronically given 100 mg.kg-1.day-1 of captopril in their drinking water beginning 1 day before uninephrectomy. Mean blood pressure was significantly decreased 4 (17%) and 8 (18%) wk later in treated rats vs. age-matched controls. When histological techniques were used, a marked reduction of medial-intimal area of the abdominal aorta was found in treated rats at 4 (24%) and 8 (15%) wk without significant change in internal diameter. Cremaster arteriolar dimensions were measured by intravital microscopy after topical application of 10(-3) M adenosine. Structural diameter reductions occurred in large arterioles starting at 4 wk in treated rats and in small arterioles at 8 wk. Despite a significant increase in wall-to-lumen ratio of some large and small arterioles in treated rats, the wall cross-sectional area of these vessels was significantly decreased by captopril. Measured by stereological techniques, small arteriolar density decreased 17% at 4 wk and 13% at 8 wk in treated rats. Although decreased blood pressure may contribute to smaller aortic cross-sectional wall area, the effect of captopril was probably the major cause for smaller arteriolar lumens, reduced arteriolar cross-sectional wall areas, and arteriolar rarefaction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2058727     DOI: 10.1152/ajpheart.1991.260.6.H1959

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Functional and neurometabolic asymmetry in SHR and WKY rats following vasoactive treatments.

Authors:  Ana B Segarra; Isabel Prieto-Gomez; Inmaculada Banegas; Magdalena Martínez-Cañamero; Juan de Dios Luna; Marc de Gasparo; Manuel Ramírez-Sánchez
Journal:  Sci Rep       Date:  2019-11-06       Impact factor: 4.379

2.  Angiotensin-Converting Enzyme Inhibition as an Adjunct to Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease.

Authors:  Katrina J Curtis; Victoria M Meyrick; Bhavin Mehta; Gulam S Haji; Kawah Li; Hugh Montgomery; William D-C Man; Michael I Polkey; Nicholas S Hopkinson
Journal:  Am J Respir Crit Care Med       Date:  2016-12-01       Impact factor: 21.405

3.  Neuropeptidase activity in the frontal cortex of Wistar-Kyoto and spontaneously hypertensive rats treated with vasoactive drugs: a bilateral study.

Authors:  Isabel Prieto; Ana B Segarra; Ana B Villarejo; Marc de Gasparo; María M Martínez-Cañamero; Manuel Ramírez-Sánchez
Journal:  J Hypertens       Date:  2019-03       Impact factor: 4.844

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.